Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1;110(6):963-978.
doi: 10.1016/j.ajhg.2023.04.008. Epub 2023 May 16.

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

Dmitrijs Rots  1 Taryn E Jakub  2 Crystal Keung  2 Adam Jackson  3 Siddharth Banka  4 Rolph Pfundt  1 Bert B A de Vries  1 Richard H van Jaarsveld  5 Saskia M J Hopman  5 Ellen van Binsbergen  5 Irene Valenzuela  6 Maja Hempel  7 Tatjana Bierhals  7 Fanny Kortüm  7 Francois Lecoquierre  8 Alice Goldenberg  8 Jens Michael Hertz  9 Charlotte Brasch Andersen  10 Maria Kibæk  11 Eloise J Prijoles  12 Roger E Stevenson  12 David B Everman  12 Wesley G Patterson  12 Linyan Meng  13 Charul Gijavanekar  13 Karl De Dios  14 Shenela Lakhani  15 Tess Levy  15 Matias Wagner  16 Dagmar Wieczorek  17 Paul J Benke  18 María Soledad Lopez Garcia  19 Renee Perrier  20 Sergio B Sousa  21 Pedro M Almeida  21 Maria José Simões  22 Bertrand Isidor  23 Wallid Deb  23 Andrew A Schmanski  24 Omar Abdul-Rahman  24 Christophe Philippe  25 Ange-Line Bruel  25 Laurence Faivre  26 Antonio Vitobello  25 Christel Thauvin  27 Jeroen J Smits  1 Livia Garavelli  28 Stefano G Caraffi  28 Francesca Peluso  28 Laura Davis-Keppen  29 Dylan Platt  29 Erin Royer  29 Lisette Leeuwen  30 Margje Sinnema  31 Alexander P A Stegmann  31 Constance T R M Stumpel  32 George E Tiller  33 Daniëlle G M Bosch  34 Stephanus T Potgieter  35 Shelagh Joss  36 Miranda Splitt  37 Simon Holden  38 Matina Prapa  38 Nicola Foulds  39 Sofia Douzgou  40 Kaija Puura  41 Regina Waltes  42 Andreas G Chiocchetti  42 Christine M Freitag  42 F Kyle Satterstrom  43 Silvia De Rubeis  44 Joseph Buxbaum  44 Bruce D Gelb  44 Aleksic Branko  45 Itaru Kushima  46 Jennifer Howe  47 Stephen W Scherer  47 Alessia Arado  48 Chiara Baldo  48 Olivier Patat  49 Demeer Bénédicte  50 Diego Lopergolo  51 Filippo M Santorelli  52 Tobias B Haack  53 Andreas Dufke  53 Miriam Bertrand  53 Ruth J Falb  53 Angelika Rieß  53 Peter Krieg  54 Stephanie Spranger  55 Maria Francesca Bedeschi  56 Maria Iascone  57 Sarah Josephi-Taylor  58 Tony Roscioli  59 Michael F Buckley  60 Jan Liebelt  61 Aditi I Dagli  62 Emmelien Aten  63 Anna C E Hurst  64 Alesha Hicks  64 Mohnish Suri  65 Ermal Aliu  66 Sunil Naik  66 Richard Sidlow  67 Juliette Coursimault  8 Gaël Nicolas  8 Hanna Küpper  68 Florence Petit  69 Veyan Ibrahim  70 Deniz Top  70 Francesca Di Cara  71 Genomics England Research Consortium  72 Raymond J Louie  12 Elliot Stolerman  12 Han G Brunner  73 Lisenka E L M Vissers  1 Jamie M Kramer  74 Tjitske Kleefstra  75
Affiliations

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

Dmitrijs Rots et al. Am J Hum Genet. .

Abstract

De novo variants are a leading cause of neurodevelopmental disorders (NDDs), but because every monogenic NDD is different and usually extremely rare, it remains a major challenge to understand the complete phenotype and genotype spectrum of any morbid gene. According to OMIM, heterozygous variants in KDM6B cause "neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities." Here, by examining the molecular and clinical spectrum of 85 reported individuals with mostly de novo (likely) pathogenic KDM6B variants, we demonstrate that this description is inaccurate and potentially misleading. Cognitive deficits are seen consistently in all individuals, but the overall phenotype is highly variable. Notably, coarse facies and distal skeletal anomalies, as defined by OMIM, are rare in this expanded cohort while other features are unexpectedly common (e.g., hypotonia, psychosis, etc.). Using 3D protein structure analysis and an innovative dual Drosophila gain-of-function assay, we demonstrated a disruptive effect of 11 missense/in-frame indels located in or near the enzymatic JmJC or Zn-containing domain of KDM6B. Consistent with the role of KDM6B in human cognition, we demonstrated a role for the Drosophila KDM6B ortholog in memory and behavior. Taken together, we accurately define the broad clinical spectrum of the KDM6B-related NDD, introduce an innovative functional testing paradigm for the assessment of KDM6B variants, and demonstrate a conserved role for KDM6B in cognition and behavior. Our study demonstrates the critical importance of international collaboration, sharing of clinical data, and rigorous functional analysis of genetic variants to ensure correct disease diagnosis for rare disorders.

Keywords: COMPASS; Drosophila; KDM6B; Mendelian disorders; de novo variants; missense variants; neurodevelopmental disorders.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.W.S. is a scientific consultant of Population Bio and the King Abdullaziz University, and Athena Diagnostics has licensed intellectual property from his work held by the Hospital for Sick Children, Toronto.

Figures

Figure 1
Figure 1
Overview of the study design and the identified KDM6B variants (A) Schematic illustration of the study design. (B) KDM6B variants, and their positions, identified in independent families. JmJC, Jumonji C domain; Zn, zinc; PTVs, protein-truncating (nonsense, frameshift, canonical splice) variants; PAVs, protein altering (missense and in-frame indel) variants.
Figure 2
Figure 2
Analysis of KDM6B PAVs via protein 3D structure analysis and a dual Drosophila gain-of-function assay (A) KDM6B fragment (PDB: 5OY3, aa 1157–1639) bound to the H3 tail fragment (aa 17–33). The JmJC domain is shown in cyan with 2-oxoglutaric acid (purple) bound with an Fe ion (magenta), which is necessary for the enzymatic demethylation of H3K27. The Zn-containing domain is shown in blue with Zn ion (magenta). Two out of three JmJC and Zn-containing domain-stabilizing linkers are also visible in the structure (orange). The H3 tail with K27 residue positioned into the active center of the JmJC domain is shown in yellow. Amino acids affected by missense or in-frame indels are shown as balls (pathogenic, red; VUSs, gray), affecting all shown domains as well as binding to H3 tail (see Table S3 for more details on specific variants). (B) A dual Drosophila gain-of-function assay was used to assess the disruptive potential of KDM6B PAVs. Ubiquitous overexpression (left) of KDM6Bref with the UAS/Gal4 system results in complete lethality. Percent lethality assessed for KDM6BΔNterm, KDM6BΔJmJC, KDM6BΔZndom, KDM6BP415Q as a benign control, and 18 KDM6B variants were compared to KDM6Bref (chi-squared test). n = 50–230 flies for each genotype; data are represented as mean ± 95% confidence interval. Wing-specific overexpression (right) of KDM6Bref in the fly wings results in the formation of an extra vein protruding off the L5 vein. The length of the extra vein was compared to KDM6Bref (Dunnet’s test). n = 18–35 flies for each sample; data are represented as mean ± SEM. PAVs are colored on the basis of the domain (JmJC, cyan; Zn-containing, blue; stabilizing linkers, orange; no domain, white; same as in Figures 1B and 2A). ∗∗p < 0.01, ∗∗∗p < 0.0001.
Figure 3
Figure 3
The Drosophila KDM6B ortholog, Utx, is required in neurons for normal memory and behavior (A) Short term (STM) and long term (LTM) courtship memory was assessed upon MB-specific expression (R14H06-Gal4) of two independent Utx RNAi lines (UtxRNAi1 and UtxRNAi2) and their genetic controls (control 1 and control 2). Boxplots show the distribution of courtship indices (CIs) for naive (N) and trained (T) male flies aged 5 days. Memory was observed when a significant reduction in CI occurred between naive and trained conditions of the same genotype (Kruskal Wallis test). All controls show a significant reduction in courtship in trained vs. naive groups, while Utx RNAi knockdown flies did not. At least 30 flies were tested per condition. (B) Naive courting behavior was pooled from short- and long-term memory assays and compared between MB-specific Utx RNAi knockdown flies and their genetic controls. At least 60 male flies aged 5 days were tested. (C and D) MB-specific Utx RNAi knockdown caused reduced daily activity (C) and increased sleep (D) compared to genetic controls, but these differences were only significant for UtxRNAi1 (t test). n = 32 flies for each genotype. (E) No morphological defects were found following MB-specific knockdown of Utx compared to their genetic controls. MB morphology was consistent in at least ten brains for each genotype. Scale bar represents 50 μm. Data are represented as mean ± SEM. p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.0001.
Figure 4
Figure 4
Photos of individuals with identified KDM6B variants Individuals with (likely) pathogenic variants are shown in the red box above, and those with a VUS are shown in the gray box.

References

    1. Gerrard D.T., Berry A.A., Jennings R.E., Birket M.J., Zarrineh P., Garstang M.G., Withey S.L., Short P., Jiménez-Gancedo S., Firbas P.N., et al. Dynamic changes in the epigenomic landscape regulate human organogenesis and link to developmental disorders. Nat. Commun. 2020;11:3920. doi: 10.1038/s41467-020-17305-2. - DOI - PMC - PubMed
    1. Ciptasari U., van Bokhoven H. The phenomenal epigenome in neurodevelopmental disorders. Hum. Mol. Genet. 2020;29:R42–R50. doi: 10.1093/hmg/ddaa175. - DOI - PMC - PubMed
    1. Kleefstra T., Schenck A., Kramer J.M., van Bokhoven H. The genetics of cognitive epigenetics. Neuropharmacology. 2014;80:83–94. doi: 10.1016/j.neuropharm.2013.12.025. - DOI - PubMed
    1. Faundes V., Newman W.G., Bernardini L., Canham N., Clayton-Smith J., Dallapiccola B., Davies S.J., Demos M.K., Goldman A., Gill H., et al. Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders. Am. J. Hum. Genet. 2018;102:175–187. doi: 10.1016/j.ajhg.2017.11.013. - DOI - PMC - PubMed
    1. Cenik B.K., Shilatifard A. COMPASS and SWI/SNF complexes in development and disease. Nat. Rev. Genet. 2021;22:38–58. doi: 10.1038/s41576-020-0278-0. - DOI - PubMed

Publication types

Substances

Supplementary concepts

Grants and funding

LinkOut - more resources